{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:31:46Z","timestamp":1792301506575,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.revmed.2014.05.009","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T17:00:12Z","timestamp":1401987612000},"page":"779-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Les an\u00e9mies h\u00e9molytiques immunologiques m\u00e9dicamenteuses\u00a0: \u00e9tude r\u00e9trospective de 10\u00a0observations"],"prefix":"10.1016","volume":"35","author":[{"given":"A.","family":"Bollotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Vial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bricca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Broussolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2014.05.009_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/asheducation-2009.1.73","article-title":"Drug-induced immune haemolytic anemia","author":"Garratty","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.revmed.2014.05.009_bib0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.21307\/immunohematology-2019-328","article-title":"An update on drug-induced immune haemolytic anemia","volume":"23","author":"Garratty","year":"2007","journal-title":"Immunohematology"},{"key":"10.1016\/j.revmed.2014.05.009_bib0015","first-page":"117","article-title":"Drug-induced haemolytic anemia. Results of consensus conferences","volume":"43","author":"Habibi","year":"1988","journal-title":"Therapie"},{"key":"10.1016\/j.revmed.2014.05.009_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.blre.2010.06.004","article-title":"Immune haemolytic anemia associated with drug therapy","volume":"24","author":"Garratty","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.revmed.2014.05.009_bib0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1517\/14740338.2012.678832","article-title":"Immune haemolytic anemia caused by drugs","volume":"11","author":"Garratty","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.revmed.2014.05.009_bib0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0248-8663(02)00688-4","article-title":"Characteristics of autoimmune haemolytic anemia in adults: retrospective analysis of 83\u00a0cases","volume":"23","author":"Genty","year":"2002","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.05.009_bib0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.revmed.2006.05.009","article-title":"Ambroxol-induced immune haemolytic anemia","volume":"27","author":"Guitard","year":"2006","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.05.009_bib0040","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1365-2141.1998.00615.x","article-title":"Positive direct antiglobulin tests and haemolytic anaemia following therapy with betalactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells","volume":"100","author":"Garratty","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2014.05.009_bib0045","series-title":"Immune haemolytic anemias","first-page":"261","author":"Petz","year":"2004"},{"key":"10.1016\/j.revmed.2014.05.009_bib0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1537-2995.2008.02028.x","article-title":"Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and\/or drug-induced nonimmunologic protein adsorption","volume":"49","author":"Arndt","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.revmed.2014.05.009_bib0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/17474086.1.2.189","article-title":"Autoimmune haemolytic anemia: classification and therapeutic approaches","volume":"1","author":"S\u00e8ve","year":"2008","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.revmed.2014.05.009_bib0060","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1046\/j.1537-2995.2003.00562.x","article-title":"A negative or very weakly positive DAT should not exclude investigation of drug-induced immune haemolytic anemia","volume":"43","author":"Leger","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.revmed.2014.05.009_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1246-7820(99)80032-9","article-title":"Application of the gel test using and anti-IgA antiglobulin for the immunologic diagnosis of autoimmune haemolytic anemia with a negative direct Coombs test","volume":"6","author":"Meyer","year":"1999","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.revmed.2014.05.009_bib0070","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ajh.23218","article-title":"The direct antiglobulin test: a critical step in the evaluation of hemolysis","volume":"87","author":"Zantek","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2014.05.009_bib0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1517\/14740330802577351","article-title":"Drug-induced immune hemolyticanemia","volume":"8","author":"Salama","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.revmed.2014.05.009_bib0080","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1537-2995.2004.03360.x","article-title":"Persistence of cefotetan on red blood cells","volume":"44","author":"Davenport","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.revmed.2014.05.009_bib0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-510X(98)00299-8","article-title":"Autoimmune events during interferon-beta-1b treatment for multiple sclerosis","volume":"162","author":"Durelli","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.revmed.2014.05.009_bib0090","first-page":"210","article-title":"Interferon-beta-1b induced autoimmune hemolyticanemia in a patient with MS: a case report","volume":"13","author":"Saeedi","year":"2011","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.revmed.2014.05.009_bib0095","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1046\/j.1537-2995.1999.39111239.x","article-title":"Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolyticanemia and\/or positive direct antiglobulin tests","volume":"39","author":"Arndt","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.revmed.2014.05.009_bib0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0973-6247.39507","article-title":"Fatal drug-induced immune haemolytic anemia due to cefotetan; a case study","volume":"2","author":"Perkins","year":"2008","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.revmed.2014.05.009_bib0105","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1537-2995.2011.03321.x","article-title":"Serologic characteristics of ceftriaxone antibodies in 25\u00a0patients with drug-induced immune haemolytic anemia (CME)","volume":"52","author":"Arndt","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.revmed.2014.05.009_bib0110","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/j.1537-2995.2008.01852.x","article-title":"Serological studies of piperacillin antibodies","volume":"48","author":"Leger","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.revmed.2014.05.009_bib0115","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1537-2995.2004.03111.x","article-title":"An immediate haemolytic reaction induced by repeated administration of oxaliplatin","volume":"44","author":"Chen","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.revmed.2014.05.009_bib0120","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(99)03827-1","article-title":"Oxaliplatin-induced haemolytic anaemia","volume":"354","author":"Desrame","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2014.05.009_bib0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.revmed.2012.05.002","article-title":"[Coma of unknown cause in a 35-year-old man]","volume":"33","author":"Gilardin","year":"2012","journal-title":"Rev Med Interne"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866314005177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866314005177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:33:30Z","timestamp":1759336410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866314005177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0248866314005177"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2014.05.009","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les an\u00e9mies h\u00e9molytiques immunologiques m\u00e9dicamenteuses\u00a0: \u00e9tude r\u00e9trospective de 10\u00a0observations","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2014.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}